FDA Approves New Treatment for Metastatic Pancreatic Cancer
A cancer patient receives treatment.Photo:GettyThere is new hope for patients with pancreatic cancer — the FDA has approved a chemotherapy treatment for patients who have not received prior treatment for the disease.According to a press release from thePancreatic Cancer Action Network, the drug, named NALIRIFOX, combines three previously approved pancreatic cancer medications: liposomal irinotecan, fluorouracil, leucovorin, and oxaliplatin.Pancreatic cancer ranks as the third leading cause of cancer-related deaths in the U....